Clinical Trial

A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this study is to evaluate safety and tolerability of single subcutaneous (SC) doses of PATAS in healthy subjects. The secondary objective of this study is to determine the pharmacokinetics (PK) of single SC doses of PATAS in healthy subjects.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-16
Trial Details
NCT Number NCT07223333
Lead Sponsor AdipoPharma LLC
Conditions Type 2 Diabetes
Enrollment 56 participants
Start Date 2026-01-27
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-15